561.404.4350 info@sriplaw.com

After an FDA warning letter told True Renewal to either register its products with the agency or change claims on its Web sites, the supplement maker has altered product descriptions. The FDA targeted five products, saying the Web sites claimed the items could be used to cure, treat or prevent disease.

Product descriptions on the Web site now differ from the FDA citations. For one product, Miracle Mineral Supplement, the FDA said that True Renewal claimed, “Hundreds of lives have been saved. Reports of overcoming incurable diseases are happening every day.”  The product page for the supplement now reads in part, “Any information provided herein is for educational purposes only and is NOT meant to diagnose, treat, cure or prevent disease.” The home page for Miracle Mineral Supplement also has this disclaimer: “The Miracle Mineral Supplement is not FDA approved and is not intended for human consumption.”

Similarly, the FDA said the company had claimed that Graviola contained compounds “that are 10,000 times stronger than chemotherapy and act only on cancer cells, not healthy cells!” Now, the Web page for Graviola lists ingredients, contraindications and drug interactions.

True Renewal is based in Provo, Utah. Three Web pages providing company and contact information list street and e-mail addresses, and a fax number. The FDA addressed its warning to Jenine M. Cohoon. According to one biography, she holds a Ph.D. in holistic nutrition. Her Web site, which the FDA cited in its letter, now has no content and points to True Renewal.


Joel B. Rothman represents clients in intellectual property infringement litigation involving patents, trademarks, copyrights, trade secrets, defamation, trade libel, unfair competition, unfair and deceptive trade practices, and commercial matters. Joel’s litigation practice also includes significant focus on electronic discovery issues such as e-discovery management and motion practice relating to e-discovery.